Drag a card by its title · ⚙ to size, swap or remove

The company

Liquidia Corporation

LQDA · Nasdaq

Health CareBiotechnologyNot moving yet

LQDA stood above a rising 150-day average in 49 of the last 52 weekly readings, and has been out of that trend for the last 3 weeks. It is 42.6% below that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 3
Industry in uptrend: 16% -15 in 4 wk
Insider buys, 12 months: $636K
Insider sales, 12 months: $448.0M
Officials’ trades on record: 4
Institutions holding: 308 (+76)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 49 of 52 weeks.

20 Apr – 19 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

4 disclosed lines: House 0, Senate 0, executive 4; 1 people.

Who	Did	Amount	Traded
Donald J. Trump Executive branch: Office of Government EthicsWhite House Office	sold	$15k–$50k	31 Aug 2026filed 8 Oct 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Office	sold	$50k–$100k	29 Jul 2026filed 22 Sep 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Office	sold	$1k–$15k	8 Jul 2026filed 22 Sep 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Office	bought	$50k–$100k	22 Jun 2026filed 22 Aug 2026

Insiders

Buy orders, 12 months2

Sale orders, 12 months126

Buyers · sellers2 · 16

Who	Did	Shares	Traded
Jason AdairChief Business Officer	sold	7,301at $28.48	12 Oct 2026filed 13 Oct 2026
Dana BoyleChief Accounting Officer	sold	5,892at $28.48	12 Oct 2026filed 13 Oct 2026
Roger JeffsChief Executive Officer	sold	32,744at $28.48	12 Oct 2026filed 13 Oct 2026
Michael KasetaCFO and COO	sold	18,938at $28.48	12 Oct 2026filed 13 Oct 2026
Sanjeev KhindriChief Development Officer	sold	1,101at $28.48	12 Oct 2026filed 13 Oct 2026
Sarah KreppChief Human Resource Officer	sold	5,245at $28.48	12 Oct 2026filed 13 Oct 2026
Scott MoomawChief Commercial Officer	sold	8,863at $28.48	12 Oct 2026filed 13 Oct 2026
Rajeev SaggarChief Medical Officer	sold	9,218at $28.48	12 Oct 2026filed 13 Oct 2026
Russell SchundlerGeneral Counsel	sold	13,692at $28.48	12 Oct 2026filed 13 Oct 2026
Stephen M. BlochDirector	sold	235,477at $27.13	5 Oct 2026filed 7 Oct 2026
Raman SinghDirector	sold	8,468at $66.16	14 Sep 2026filed 15 Sep 2026
Raman SinghDirector	sold	9,024at $68.62	11 Sep 2026filed 15 Sep 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders308+76 on the quarter

New · exited111 · 35

Reported value$5.6B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
BlackRock, Inc.added · filed 7 Aug 2026	10,788,586$860.2M	+5,299,442+96.5%
FARALLON CAPITAL MANAGEMENT, L.L.C.reduced · filed 14 Aug 2026	8,365,038$666.9M	-291,000−3.4%
Caligan Partners LPunchanged · filed 14 Aug 2026	8,118,892$647.3M	00.0%
FINDELL CAPITAL MANAGEMENT LLCunchanged · filed 14 Aug 2026	3,502,112$279.2M	00.0%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	3,139,183$250.3M	+212,238+7.3%
STATE STREET CORPadded · filed 7 Aug 2026	3,030,395$241.6M	+1,148,796+61.1%
Opaleye Management Inc.reduced · filed 14 Aug 2026	2,447,500$195.1M	-97,500−3.8%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026	2,121,290$169.2M	+192,321+10.0%
BANK OF AMERICA CORPreduced · filed 14 Aug 2026	1,991,566$158.8M	-296,226−12.9%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026	1,532,151$122.2M	+899,526+142.2%